aspartate-beta-hydroxamate has been researched along with Cholangiocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noda, T; Ortiz, V; Shimoda, M; Sirica, AE; Wands, JR | 1 |
1 other study(ies) available for aspartate-beta-hydroxamate and Cholangiocarcinoma
| Article | Year |
|---|---|
Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
Topics: Adoptive Transfer; Animals; Asparagine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Division; Cells, Cultured; Cholangiocarcinoma; Dendritic Cells; Disease Models, Animal; Humans; Immunization; Interleukin-12; Male; Rats; Rats, Inbred F344; Recombinant Proteins; Spleen | 2012 |